TYMS and cancer: This indicates that the impact of folate modulation is multifactorial, depending on the type and stage of cancer [14], the folate dosage [15], the presence of additional risk factors [16], or nucleotide polymorphism within the methylenetetrahydrofolate reductase (MTHFR) and thymidylate synthase (TS) genes [17], respectively.